EDGAR Filing Documents for 0001104659-15-027692

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001104659-15-027692

Filing Date

2015-04-15

Accepted

2015-04-15 16:42:24

Documents

Effectiveness Date

2015-04-15

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	a15-8858_3defa14a.htm	DEFA14A	48069
2	GRAPHIC	g88583bci001.gif	GRAPHIC	4943
3	GRAPHIC	g88583bci002.jpg	GRAPHIC	1362
4	GRAPHIC	g88583bci003.jpg	GRAPHIC	1362
	Complete submission text file	0001104659-15-027692.txt		60250

Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034

Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000

Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36617 | Film No.: 15772114
SIC: 2834 Pharmaceutical Preparations